Stuart J Mundell

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 3

Top Topics

Percutaneous Coronary Intervention

Antiplatelet Therapy

St Segment Elevation Myocardial Infarction

Top Venues

British journal of pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Megan F Allen, James L Hutchinson, Michael Keith, Shahida Mallah, Robin Adam Corey, Justin S Trory, Changcheng Jing, Huaquan Fang, Liang Wei, Steven H Bennett, Varinder Kumar Aggarwal, Stuart J Mundell, Ingeborg Hers
Difluorinated thromboxane A 2 reveals crosstalk between platelet activatory and inhibitory pathways by targeting both the TP and IP receptors. British journal of pharmacology (2024)
Megan F Allen, James L Hutchinson, Michael Keith, Shahida Mallah, Robin Adam Corey, Justin S Trory, Changcheng Jing, Huaquan Fang, Liang Wei, Steven H Bennett, Varinder Kumar Aggarwal, Stuart J Mundell, Ingeborg Hers
Difluorinated thromboxane A 2 reveals crosstalk between platelet activatory and inhibitory pathways by targeting both the TP and IP receptors. British journal of pharmacology 181 (19) (2024)
Jawad Khalil, Tudor Dimofte, Timothy Roberts, Michael Keith, Kumuthu Amaradasa, Matthew S Hindle, Sukhinder Bancroft, James L Hutchinson, Khalid Naseem, Thomas Johnson, Stuart J Mundell
Ticagrelor inverse agonist activity at the P2Y 12 receptor is non-reversible versus its endogenous agonist ADP. British journal of pharmacology (2023)